Stockreport

Ideaya Biosciences: Primed For Success - Major Eye Cancer Catalyst Weeks Away [Seeking Alpha]

IDEAYA Biosciences, Inc.  (IDYA) 
Last ideaya biosciences, inc. earnings: 3/24 06:00 am Check Earnings Report
PDF IDYA's darovasertib shows promising Phase 2 results and multiple pivotal studies, with a potential $500M+ peak revenue opportunity and a strong partnership with Servier [Read more]